Quantitative Systematic Strategies LLC Xenon Pharmaceuticals Inc. Transaction History

Quantitative Systematic Strategies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$14.86 - $19.45 $183,416 - $240,071	-12,343 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$16.81 - $20.0 $216,260 - $257,300	-12,865 Reduced 51.04%	12,343 $230,000
Q1 2021 May 06, 2021	SELL	$13.65 - $21.31 $55,637 - $86,859	-4,076 Reduced 13.92%	25,208 $451,000
Q4 2020 Feb 09, 2021	BUY	$9.49 - $16.04 $164,461 - $277,973	17,330 Added 144.97%	29,284 $450,000
Q3 2020 Nov 09, 2020	BUY	$10.82 - $13.35 $3,007 - $3,711	278 Added 2.38%	11,954 $132,000
Q2 2020 Aug 04, 2020	BUY	$10.21 - $14.9 $119,211 - $173,972	11,676 New	11,676 $146,000

212

70.2M

88.3K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.39B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.